MUDr. Martin Štork, Ph.D.
Assistant, Department of Internal Medicine, Hematology and Oncology
Phone: | +420 532 23 3517, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 61
2023
-
Comprehensive NGS testing allows integrated assessment of individual patient prognosis in multiple myeloma.
Year: 2023, type: Conference abstract
-
Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
Annals of Hematology, year: 2023, volume: 102, edition: 6, DOI
-
Improved Screening of Monoclonal Gammopathy Patients by MALDI-TOF Mass Spectrometry
Journal of the American Society for Mass Spectrometry, year: 2023, volume: 34, edition: 12, DOI
-
More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia-Like Multiple Myeloma
Journal of clinical oncology, year: 2023, volume: 41, edition: 7, DOI
2022
-
CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity
Neoplasma, year: 2022, volume: 69, edition: 5, DOI
-
Identification of genetic aberrations in multiple myeloma patients with low tumour burden using comprehensive NGS testing.
Year: 2022, type: Conference abstract
-
Identification of patients at high risk of secondary extramedullary multiple myeloma development
British journal of haematology, year: 2022, volume: 196, edition: 4, DOI
-
Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma
International Journal of Molecular Sciences, year: 2022, volume: 23, edition: 23, DOI
-
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy
Cancers, year: 2022, volume: 14, edition: 20, DOI
-
Komplexní analýza nádorového genomu pacientů s mnohočetným myelomem.
Year: 2022, type: Conference abstract